TrialThrombosis and haemostasis2011

Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia.

Margaret V Ragni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.